Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Chimp in a tree, for article on carbon financing biodiversity

Birdsong and chimp drumming suggest carbon financing is helping Sierra Leone’s forest

By / / Good News For Humankind

Carbon financing in Sierra Leone’s Gola Rainforest is doing more than locking away carbon — it’s bringing the forest back to life, according to a new study in Conservation Science and Practice. Researchers recorded audio at 133 sites and found the protected park’s dawn chorus was measurably richer than the community forest right next door, with the shift happening sharply at the border. The idea, drawn from the acoustic niche hypothesis, is that more species means more sound frequencies filled, like instruments in an orchestra each holding a lane. It’s one of the first direct signs that REDD+ programs, long sold on climate grounds, may genuinely shelter biodiversity too — a hopeful nudge for how the world funds living forests everywhere.

New York City park, for article on urban forest plan

New York City’s first urban forest plan targets its hottest, least-shaded blocks

By / / Good News For Humankind

New York City’s first Urban Forest Plan aims to grow tree canopy from 23.4% to 30% of the city’s surface by 2040, with a focus on neighborhoods that have been left in the sun for too long. Right now, environmental justice communities sit under about 19% canopy cover, while wealthier areas enjoy 26% — a gap you can feel on a hot summer afternoon. The plan protects existing trees, expands planting on streets and private land, and trains residents, including NYCHA tenants, to care for the urban forest. It’s a hopeful reminder that shade, cooler air, and cleaner streets are infrastructure every neighborhood deserves.

Depiction of DNA, for article on gene therapy for inherited deafness

U.S. FDA approves first-ever gene therapy for inherited deafness, free to patients

By / / Good News For Humankind

The FDA has approved the first-ever gene therapy for inherited deafness. In its 20-child trial, 16 saw their hearing improve within months — and some could make out whispers for the first time.
Called Otarmeni, the one-time treatment uses two harmless viruses to deliver working copies of the OTOF gene deep into the inner ear, restoring otoferlin, the protein the cochlea needs to turn sound into signals the brain can read. Its maker, Regeneron, says it will offer the therapy free to patients in the U.S. Doctors who ran the trial described children responding to their parents’ voices, and to music, for the first time.
This particular genetic form of deafness is rare, affecting roughly 50 babies born in the U.S. each year. But researchers believe the breakthrough cracks open the door to gene therapies for many other inherited conditions worldwide.

Nairobi skyline, for article on gender marker ruling

Kenya’s High Court rules trans people’s gender-marker applications must be heard

By / / Good News For Humankind

Kenya’s trans community just won a major legal victory: a High Court has given government agencies 60 days to start accepting applications to update gender markers on IDs, passports, birth certificates, and academic records. Justice Bahati Mwamuye ruled that the state’s refusal to make those changes is unconstitutional, writing that “the silence and delay cannot defeat rights.” The decision caps more than a decade of patient legal work led by advocate Audrey Mbugua Ithibu and others, who described being interrogated at airports, banks, and hospitals whenever their documents didn’t match who they are. Beyond Kenya, the ruling adds momentum to a global understanding that accurate identity documents aren’t a bureaucratic detail — they’re the foundation for dignity, safety, and full participation in public life.

Finger prick insulin injection, for article on once-weekly insulin

Once-weekly insulin wins U.S. approval, cutting 365 injections a year to 52

By / / Good News For Humankind

Once-weekly insulin just became reality in the U.S., dropping the routine for many adults with type 2 diabetes from 365 shots a year to about 52. The FDA approved Awiqli after four phase 3 trials, covering 2,680 adults, found it matched or outperformed daily basal insulin in lowering blood glucose. For people already taking a weekly GLP-1 medication, pairing the two could mean far fewer injection days and one less thing to remember. Doctors are urging thoughtful, individualized use, especially around hypoglycemia risk and affordability. Still, with more than 500 million adults living with diabetes worldwide, treatments that make daily life easier are a quietly powerful step forward for global health.

River Wye, for article on River Wye rights charter

River Wye recognized as a living ecosystem with rights in a U.K. first

By / / Good News For Humankind

The River Wye just became the first entire river catchment in the U.K. to be formally recognized as a living ecosystem with intrinsic rights, covering its full 130-mile journey from the Cambrian mountains to the Bristol Channel. Herefordshire and Powys councils have already signed the new charter, with two more expected to follow. Ecologist Dr. Louise Bodnar has been appointed the river’s first formal voice, holding a voting seat on the catchment’s nutrient management board. It’s a quietly radical idea — that a river deserves a seat at the table where its future is decided — and it adds real momentum to a growing global movement giving nature legal standing of its own.

Beijing skyline, for article on China CO2 emissions

Clean energy holds China’s emissions flat for two years without an economic slowdown

By / / Good News For Humankind

China’s CO2 emissions have now stayed flat or declining for 21 straight months — a first in modern history, and one that’s happening while the economy keeps growing. New analysis from Carbon Brief estimates emissions dipped 0.3% in 2025, as a 43% surge in solar generation and a 14% rise in wind together absorbed nearly all the year’s added electricity demand. Even more striking, China added 75 gigawatts of battery storage — outpacing peak demand growth and weakening the long-standing case for new coal plants. If this pattern holds, the world’s largest emitter may be quietly showing every country what it looks like when clean energy stops chasing demand and starts outrunning it.

Professional office, for article on four-day work week

Four-day week cut burnout without cutting output, Australian study finds

By / / Good News For Humankind

Four-day work weeks held up beautifully in a two-year Australian trial just published in a Nature Portfolio journal — 14 of the 15 companies involved decided to keep the shorter week for good. Six actually saw productivity rise, and the rest held steady. The secret wasn’t cramming five days into four, but rethinking the work itself: cutting pointless meetings, automating repetitive tasks, and letting people focus on what mattered. Six of the companies said their main motivation was easing burnout, which a 2025 Beyond Blue survey found affects one in two Australian workers. As AI reshapes what humans actually need to do at work, this quiet experiment suggests a hopeful answer to where those reclaimed hours could go — back to us.

United Nations building in NYC, for article on ICJ climate ruling

U.N. General Assembly backs landmark World Court ruling on nations’ climate obligations

By / / Good News For Humankind

Climate accountability took a historic leap forward when the UN General Assembly voted 141 to 8 to endorse a landmark International Court of Justice ruling that treats climate action as a legal obligation rather than a political choice. The resolution, drafted by the Pacific island nation Vanuatu after years of patient advocacy, affirms that states breaching their climate duties may be required to halt the harm and offer reparation. Secretary-General António Guterres called it a victory for the planet, noting that the path to justice runs through a swift, equitable shift to renewables. For frontline communities everywhere, this reframing matters: climate protection is no longer just good policy — it’s a right they can claim.

Child getting hearing test, for article on gene therapy for deafness

U.S. FDA approves first gene therapy for inherited deafness, offered free to U.S. patients

By / / Good News For Humankind

Gene therapy can now restore hearing to children born deaf — and Regeneron is giving it away free to U.S. families. In a trial of 20 children with rare OTOF mutations, 16 gained meaningful hearing within about five months, and several were brought to essentially normal hearing. One toddler covered his ears when an ambulance siren passed — his first sign of sound. Instead of charging up to $4 million per child, as is common for rare-disease therapies, Regeneron chose a different path entirely. Beyond the families it directly helps, the decision hints at a quietly radical idea: that breakthrough medicine for rare conditions doesn’t have to come with a breathtaking price tag.